INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300,643 | -35.1% | 9,508 | -16.3% | 0.02% | -35.7% |
| Q2 2023 | $463,221 | -8.8% | 11,359 | -16.6% | 0.03% | -17.6% |
| Q1 2023 | $507,842 | +59.7% | 13,626 | +49.5% | 0.03% | +47.8% |
| Q4 2022 | $318,022 | -56.7% | 9,115 | -30.5% | 0.02% | -58.2% |
| Q3 2022 | $734,000 | -3.7% | 13,112 | -10.9% | 0.06% | 0.0% |
| Q2 2022 | $762,000 | -26.9% | 14,717 | +2.5% | 0.06% | -6.8% |
| Q1 2022 | $1,043,000 | +13.0% | 14,355 | +83.9% | 0.06% | +13.5% |
| Q4 2021 | $923,000 | -31.1% | 7,805 | -21.8% | 0.05% | -40.9% |
| Q3 2021 | $1,339,000 | -28.2% | 9,984 | -13.3% | 0.09% | -32.3% |
| Q2 2021 | $1,865,000 | +122.6% | 11,521 | +10.3% | 0.13% | +97.0% |
| Q1 2021 | $838,000 | +140.8% | 10,441 | +63.1% | 0.07% | +106.2% |
| Q4 2020 | $348,000 | – | 6,403 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |